4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-25-012591
CHIEF OPERATING OFFICER sold 6,667 shares at an average $18.39 ($122,579)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Patel Anish · CHIEF OPERATING OFFICER
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-07 | Sale : show line 1 in the form 10b5-1 | −6,173 | $18.30 | $112,947 | 310,470 | I |
| 2025-05-07 | Sale : show line 2 in the form 10b5-1 | −390 | $19.40 | $7,565 | 310,080 | I |
| 2025-05-07 | Sale : show line 3 in the form 10b5-1 | −104 | $19.87 | $2,067 | 309,976 | I |
| Open-market sales · 6,667 sh · avg $18.39 · $122,579 | ||||||
Loading xslF345X05/form4-05092025_100535.xml…